4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-004716
Options or other derivatives
- Chief Financial Officer acquired 13,888 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cook Kevin Leon Chief Financial Officer | 2022-02-11 | Grant or award · Restricted Stock Units | +13,888 | 13,888 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…